167 related articles for article (PubMed ID: 34653235)
1. Tau fibril with membrane lipids: Insight from computational modeling and simulations.
Barredo PA; Fernandez MJF; Ambe CE; Balanay MP
PLoS One; 2021; 16(10):e0258692. PubMed ID: 34653235
[TBL] [Abstract][Full Text] [Related]
2. Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling.
Murugan NA; Nordberg A; Ågren H
ACS Chem Neurosci; 2018 Jul; 9(7):1757-1767. PubMed ID: 29630333
[TBL] [Abstract][Full Text] [Related]
3. Exploring Tau Fibril-Disaggregating and Antioxidating Molecules Binding to Membrane-Bound Amyloid Oligomers Using Machine Learning-Enhanced Docking and Molecular Dynamics.
Segura L; Santos N; Flores R; Sikazwe D; McGibbon M; Blay V; Cheng KH
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930883
[TBL] [Abstract][Full Text] [Related]
4. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
Murugan NA; Nordberg A; Ågren H
ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
Caillon L; Lequin O; Khemtémourian L
Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
[TBL] [Abstract][Full Text] [Related]
6. Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer's Disease.
Pradeepkiran JA; Reddy PH
Cells; 2019 Mar; 8(3):. PubMed ID: 30893872
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Amyloid Forming Tendency of Peptide Sequences from Amyloid Beta and Tau Proteins Using Force-Field, Semi-Empirical, and Density Functional Theory Calculations.
Muvva C; Murugan NA; Subramanian V
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806726
[TBL] [Abstract][Full Text] [Related]
8. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments.
Alonso A; Zaidi T; Novak M; Grundke-Iqbal I; Iqbal K
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6923-8. PubMed ID: 11381127
[TBL] [Abstract][Full Text] [Related]
9. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.
Hanger DP; Betts JC; Loviny TL; Blackstock WP; Anderton BH
J Neurochem; 1998 Dec; 71(6):2465-76. PubMed ID: 9832145
[TBL] [Abstract][Full Text] [Related]
10. Oxidized and phosphorylated synthetic peptides corresponding to the second and third tubulin-binding repeats of the tau protein reveal structural features of paired helical filament assembly.
Hoffmann R; Dawson NF; Wade JD; Otvös L
J Pept Res; 1997 Aug; 50(2):132-42. PubMed ID: 9273897
[TBL] [Abstract][Full Text] [Related]
11. Molecular Understanding of Aβ-hIAPP Cross-Seeding Assemblies on Lipid Membranes.
Zhang M; Hu R; Ren B; Chen H; Jiang B; Ma J; Zheng J
ACS Chem Neurosci; 2017 Mar; 8(3):524-537. PubMed ID: 27936589
[TBL] [Abstract][Full Text] [Related]
12. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
Keck S; Nitsch R; Grune T; Ullrich O
J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
[TBL] [Abstract][Full Text] [Related]
14. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
15. X-ray structure of the PHF core C-terminus: insight into the folding of the intrinsically disordered protein tau in Alzheimer's disease.
Sevcik J; Skrabana R; Dvorsky R; Csokova N; Iqbal K; Novak M
FEBS Lett; 2007 Dec; 581(30):5872-8. PubMed ID: 18061582
[TBL] [Abstract][Full Text] [Related]
16. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.
Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G
Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.
Hernandes-Alejandro M; Montaño S; Harrington CR; Wischik CM; Salas-Casas A; Cortes-Reynosa P; Pérez Salazar E; Cazares-Apatiga J; Apatiga-Perez R; Ontiveros Torres MÁ; Perry G; Pacheco-Herrero M; Luna-Muñoz J
J Alzheimers Dis; 2020; 76(2):553-569. PubMed ID: 32538846
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
19. Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats.
Georgieva ER; Xiao S; Borbat PP; Freed JH; Eliezer D
Biophys J; 2014 Sep; 107(6):1441-52. PubMed ID: 25229151
[TBL] [Abstract][Full Text] [Related]
20. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau.
Matsuo ES; Shin RW; Billingsley ML; Van deVoorde A; O'Connor M; Trojanowski JQ; Lee VM
Neuron; 1994 Oct; 13(4):989-1002. PubMed ID: 7946342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
